UPDATE 1-Eli Lilly, AbCellera Biologics to co-develop coronavirus therapies

Eli Lilly Co and privately-held AbCellera Biologics Inc on Thursday announced they would co-develop antibody products for the treatment and prevention of COVID-19, a flu-like disease caused by the fast-spreading coronavirus.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.